Recently, Lorenzatti and colleagues found that CCN6, a tumor inhibitory protein, could suppress the expression of EMT transcriptional factor ZEB1 in breast cancer cells through attenuation of IGF-1R signaling [26]. Here, CCN6 is linked to breast carcinoma.